“Blood has always been considered free from microbes, because bacteria don’t grow when it is put in a culture dish. But recent DNA sequencing methods reveal that each millilitre of blood in fact contains around 1000 bacterial cells..

These bacteria are usually dormant. But they can be revived when iron becomes available in the blood, and….. stimulate inflammation. Further research could open up several new approaches for tackling them, from removing dormant microbes from our blood, to blocking the inflammatory proteins that they shed.”

Click here to view.

September 2016

The University of Melbourne unlocks a new treatment for antibiotic-resistant pathogens.
“The team discovered that their star-shaped peptide polymers can kill bacteria with multiple pathways, unlike most antibiotics which kill with a single pathway. They believe that this accounts for the superior performance of the star-shaped peptide polymers over antibiotics. One of these pathways includes ‘ripping apart’ the bacteria cell wall.”

Click here to view
September 2016

Wyatt said that although UK bodies such as the NHS and watchdog NICE describe the treatment as experimental, about 80% of people who had the treatment responded to some degree and more than 50% saw the progression of their MS halted. The charity the MS Society says the treatment could have long-term benefits for some people with MS but that larger studies are needed to better understand the impact of this aggressive treatment compared with existing therapies.

Click here to view.

Click here to view Lancet paper (June 2016).

Is MS caused by a bacteria?  Dr David Wheldon of London, UK and Dr Paul Thibault of Newcastle, Australia think so! 

“The bacteria lives INSIDE the cell and it’s good at hiding from your immune system, so no antibodies are generated against it.” Sound familiar?

This video from August 2012 about Multiple Sclerosis / Chlamydia Pneumoniae has many parallels with the CD / MAP story, including triple antibiotic therapy. Barry Marshall’s success with Helicobacter Pylori is also mentioned.   

Click here to view.

Also check out BBC correspondent Caroline Wyatt’s stem cell treatment for MS: http://www.bbc.co.uk/news/health-36490315

Is IBD two diseases – or three? For those of you who are interested in the genetic element of Inflammatory Bowel Disease, this article from The Lancet provides food for thought.
“Our data support a continuum of disorders within inflammatory bowel disease, much better explained by three groups (ileal Crohn’s disease, colonic Crohn’s disease, and ulcerative colitis) than by Crohn’s disease and ulcerative colitis as currently defined. Disease location is an intrinsic aspect of a patient’s disease, in part genetically determined, and the major driver to changes in disease behaviour over time.”

Click here to read.

Jan 2016

“The incidence of Paediatric IBD is primarily increasing among adolescents, challenging the identification of the possible environmental triggers for the disease.”
This paper calls for further investigation into environmental causes of IBD. We’d like to see more recognition of MAP as a key trigger for many Crohn’s patients.

Click here to read.

February 2017